Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$4.40 USD
+0.13 (3.04%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.42 +0.02 (0.45%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for Boundless Bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | NA | NA | NA |
Cost Of Goods | 0 | 0 | NA | NA | NA |
Gross Profit | 0 | 0 | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 55 | 46 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -55 | -46 | 0 | 0 | 0 |
Non-Operating Income | 5 | 1 | NA | NA | NA |
Interest Expense | 0 | 0 | NA | NA | NA |
Pretax Income | -49 | -46 | NA | NA | NA |
Income Taxes | 0 | 0 | NA | NA | NA |
Minority Interest | 0 | 0 | NA | NA | NA |
Investment Gains/Losses | 0 | 0 | NA | NA | NA |
Other Income/Charges | 0 | 0 | NA | NA | NA |
Income From Cont. Operations | -49 | -46 | NA | NA | NA |
Extras & Discontinued Operations | 0 | 0 | NA | NA | NA |
Net Income (GAAP) | -49 | -46 | NA | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -54 | -46 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | NA | NA | NA |
Income After Depreciation & Amortization | -55 | -46 | 0 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -40.65 | NA | NA | NA | NA |
Fiscal Year end for Boundless Bio, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | NA | NA | 0.00 |
Cost Of Goods | 0.00 | 0.00 | NA | NA | 0.00 |
Gross Profit | 0.00 | 0.00 | NA | NA | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 19.40 | 16.88 | 0.00 | 0.00 | 13.97 |
Income After SG&A, R&D, and Dept/Amort Expenses | -19.40 | -16.88 | 0.00 | 0.00 | -13.97 |
Non-Operating Income | 2.42 | 1.45 | NA | NA | 1.56 |
Interest Expense | 0.00 | 0.00 | NA | NA | 0.00 |
Pretax Income | -16.98 | -15.43 | NA | NA | -12.40 |
Income Taxes | 0.00 | 0.00 | NA | NA | 0.00 |
Minority Interest | 0.00 | 0.00 | NA | NA | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | NA | NA | 0.00 |
Other Income/Charges | 0.00 | 0.00 | NA | NA | 0.00 |
Income From Cont. Operations | -16.98 | -15.43 | NA | NA | -12.40 |
Extras & Discontinued Operations | 0.00 | 0.00 | NA | NA | 0.00 |
Net Income (GAAP) | -16.98 | -15.43 | NA | NA | -12.40 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 22.02 | 1.26 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.77 | -12.27 | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.77 | -12.27 | NA | NA | NA |